These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 30327651)

  • 1. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
    Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8
    Wen J; Tang WW; Sheets N; Ellison J; Sette A; Kim K; Shresta S
    Nat Microbiol; 2017 Mar; 2():17036. PubMed ID: 28288094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
    Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
    Rivino L; Kumaran EA; Jovanovic V; Nadua K; Teo EW; Pang SW; Teo GH; Gan VC; Lye DC; Leo YS; Hanson BJ; Smith KG; Bertoletti A; Kemeny DM; MacAry PA
    J Virol; 2013 Mar; 87(5):2693-706. PubMed ID: 23255803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4
    Rivino L; Lim MQ
    Immunology; 2017 Feb; 150(2):146-154. PubMed ID: 27763656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
    Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive Dengue virus-specific CD8
    Regla-Nava JA; Elong Ngono A; Viramontes KM; Huynh AT; Wang YT; Nguyen AT; Salgado R; Mamidi A; Kim K; Diamond MS; Shresta S
    Nat Commun; 2018 Aug; 9(1):3042. PubMed ID: 30072692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus-reactive CD8
    Wen J; Elong Ngono A; Regla-Nava JA; Kim K; Gorman MJ; Diamond MS; Shresta S
    Nat Commun; 2017 Nov; 8(1):1459. PubMed ID: 29129917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.
    Mladinich KM; Piaskowski SM; Rudersdorf R; Eernisse CM; Weisgrau KL; Martins MA; Furlott JR; Partidos CD; Brewoo JN; Osorio JE; Wilson NA; Rakasz EG; Watkins DI
    Immunogenetics; 2012 Feb; 64(2):111-21. PubMed ID: 21881953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections.
    Mapalagamage M; Weiskopf D; Sette A; De Silva AD
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
    Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
    J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.
    Piazza P; Campbell D; Marques E; Hildebrand WH; Buchli R; Mailliard R; Rinaldo CR
    Clin Exp Immunol; 2014 Sep; 177(3):696-702. PubMed ID: 24816171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
    Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.